Induction of allograft tolerance in the absence of Fas-mediated apoptosis

Journal of Immunology

Volumn 163, Issue 5, 1999, Pages 2500-2507

  Li, Xian Chang ^a   Li, Yongsheng ^a   Dodge, Ingrid ^a   Wells, Andrew D ^b   Zheng, Xin Xiao ^a   Turka, Laurence A ^b   Strom, Terry B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; RAPAMYCIN;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; HEART TRANSPLANTATION; IMMUNE TOLERANCE; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED MRL LPR; MICE, MUTANT STRAINS; T-LYMPHOCYTES; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0344199379     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Houssaint, E., and M. Flajnik. 1990. The role of thymic epithelium in the acquisition of tolerance. Immunol. Today 11:357.
2. Ikuta, K., N. Uchida, J. Friedman, and I. L. Weissman. 1992. Lymphocyte development from stem cells. Annu. Rev. Immunol. 10:759.
3. Sykes, M. 1996. Chimerism and central tolerance. Curr. Opin. Immunol. 8:694.
4. Steiger, J., P. W. Nickerson, W. Steurer, M. Moscovitch-Lopatin, and T. B. Strom. 1995. IL-2 knockout recipient mice reject islet cell allografts. J. Immunol. 155:489.
5. Li, X. C., X. X. Zheng, M. S. Zand, Y. Li, and T. B. Strom. 1998. IL-2 dependent rapamycin resistant signals are required for tolerance induction and T cell apoptosis. Transplantation 65:S169.
6. Dai, Z., B. T. Konieczny, F. K. Baddoura, and F. G. Lakkis. 1998. Impaired alloantigen mediated T cell apoptosis and failure to induce long term allograft survival in IL-2 deficient mice. J. Immunol. 161:1659.
7. Perez, V. L., L. V. Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
8. Parijs, L. V., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
9. Lenardo, M. J. 1991. Interleukin-2 programs mouse T lymphocytes for apoptosis. Nature 353:858.
10. Lau, H. T., M. Yu, A. Fontana, and C. J. Stoeckert, Jr. 1996. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273:109.
11. Zhang, H., X. Su, D. Liu, W. Liu, P. Yang, Z. Wang, C. K. Edwards, H. Bluethmann, J. D. Mountz, and T. Zhou. 1999. Induction of specific T cell tolerance by Fas ligand expressing antigen presenting cells. J. Immunol. 162: 1423.
12. George, J. F., S. D. Sweeney, J. K. Kirklin, E. M. Simpson, D. R. Goldstein, and J. M. Thomas. 1998. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nat. Med. 4:333.
13. Li, X. C., P. Roy-Chaudhury, W. W. Hancock, R. C. Manfro, M. S. Zand, Y. Li, X. X. Zheng, J. Steiger, P. W. Nickerson, T. R. Malek, and T. B. Strom. 1998. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. J. Immunol. 161:890.
14. Larsen, C. P., P. J. Morris, and J. M. Austyn. 1990. Migration of dendritic leukocytes from cardiac allografts into host spleens. J. Exp. Med. 171:307.
15. Tivol, E. A., S. D. Boyd, S. McKeon, F. Borriello, P. W. Nickerson, T. B. Strom, and A. H. Sharpe. 1997. CTLA-4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4 deficient mice. J. Immunol. 158:5091.
16. Ishaque, A., and M. Al-Rubeai. 1998. Use of intracellular pH and annexin V flow cytometric assays to monitor apoptosis and its suppression by bcl-2 overexpression in hybridoma cell culture. J. Immunol. Methods 221:43.
17. Wells, A. D., H. Gudmundsdottir, and L. A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion. J. Clin. Invest. 100:3173.
18. Song, H. K., H. Noorchashm, Y. K. Lieu, S. Rostami, S. A. S. Greeley, C. F. Barker, and A. Naji. 1999. Alloimmune responses against major and minor histocompatibility antigens: distinct division kinetics and requirement for CD28 costimulation. J. Immunol. 162:2467.
19. Abraham, R. T., and G. J. Wiederrecht. 1996. Immunopharmacology of rapamycin. Annu. Rev. Immunol. 14:483.
20. Li, Y., X. X. Zheng, X. C. Li, M. S. Zand, and T. B. Strom. 1998. Combined costimulation blockade plus rapamycin but not cyclosporine induced permanent cardiac allograft survival. Transplantation 66:1387.
21. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, K. J. Winn, and T. C. Pearson. 1996. Long term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434.
22. Nickerson, P. W., X. X. Zheng, J. Steiger, A. W. Steele, W. Steurer, P. Roy-Chaudhury, W. Muller, and T. B. Strom. 1996. Prolonged islet allograft acceptance in the absence of interleukin-4 expression. Transplant Immunol. 4:81.
23. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348.
24. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76:969.
25. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630.
26. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand induced apoptosis as a mechanism of immune privilege. Science 270: 1189.
27. Griffith, T. S., X. Yu, J. M. Herndon, D. R. Green, and T. A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5:7.
28. Chen, J. J., Y. Sun, and G. J. Nabel. 1998. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 282:1714.
29. Horak, I., J. Lohler, A. Ma, and K. A. Smith. 1995. IL-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol. Rev. 148:35.
30. Refaeli, Y., L. V. Parijs, C. A. London, J. Tschopp, and A. K. Abbas. 1998. Biochemical mechanisms of IL-2 regulated Fas mediated T cell apoplosis. Immunity 8:615.
31. Tschopp, J., M. Irmler, and M. Thome. 1998. Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10:552.
32. Gutierrez-Ramos, J. C., J. L. Andreu, Y. Revilla, E. Vinuela, and C. Martinez-A. 1990. Recovery from autoimmunity of MRL/lpr mice after infection with an IL-2/vaccinia recombinant virus. Nature 346:271.
33. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.